Registration number: 07199879

Bioscience IP Limited

Contents

Company Information	1
Balance Sheet	2
Notes to the Unaudited Financial Statements	3 to 5

Bioscience IP Limited

Company Information

Director

Mr P C Banford

Registered office

11 Lostock Hall Road Poynton Cheshire SK12 1DP

Accountants

Bright Partnership Limited Suite 1 Armcon Business Park, London Road South Poynton Cheshire SK12 1LQ

Bioscience IP Limited

(Registration number: 07199879)
Balance Sheet as at 31 March 2025

	Note	2025 £	2024 £
Fixed assets
Tangible assets	4	174	227
Current assets
Debtors	5	1,803	8,332
Cash at bank and in hand		29,598	25,790
		31,401	34,122
Creditors: Amounts falling due within one year	6	(30,927)	(18,223)
Net current assets		474	15,899
Total assets less current liabilities		648	16,126
Provisions for liabilities		(33)	(94)
Net assets		615	16,032
Capital and reserves
Called up share capital		103	100
Retained earnings		512	15,932
Shareholders' funds		615	16,032

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 10 September 2025
 

......................................... Mr P C Banford Director

Bioscience IP Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

1	General information

Bioscience IP Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

These financial statements were authorised for issue by the director on 10 September 2025.

2	Accounting policies

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and
Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or
directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Bioscience IP Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Plant and machinery etc	33% on cost and 15% on cost

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3	Staff numbers

The average number of persons employed by the company (including the director) during the year, was 3 (2024 - 3).

Bioscience IP Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2025

4	Tangible fixed assets

	Plant and machinery  £	Total £
Cost or valuation
At 1 April 2024	20,027	20,027
Additions	94	94
At 31 March 2025	20,121	20,121
Depreciation
At 1 April 2024	19,800	19,800
Charge for the year	147	147
At 31 March 2025	19,947	19,947
Carrying amount
At 31 March 2025	174	174
At 31 March 2024	227	227

5	Debtors: amounts falling due within one year

	2025 £	2024 £
Trade debtors	1,593	8,097
Other debtors	210	235
	1,803	8,332

6

Creditors

Creditors: amounts falling due within one year

	2025 £	2024 £
Due within one year
Trade creditors	11,724	-
Taxation and social security	15,134	15,309
Other creditors	4,069	2,914
	30,927	18,223